{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:07:35Z","timestamp":1793275655431,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bulcan.2024.07.013","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T06:06:48Z","timestamp":1742969208000},"page":"638-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Chondrosarcomas: Multidisciplinary review and practical recommendations, on behalf of GroupOs"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4860-305X","authenticated-orcid":false,"given":"Pascaline","family":"Boudou-Rouquette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Sunyach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Larousserie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude Marie","family":"Cardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Piperno-Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Bompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzague","family":"de Pinieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Gouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayla","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Cromb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Helfre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Feydy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Faruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Biau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bulcan.2024.07.013_bib0375","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.suronc.2018.05.009","article-title":"Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas","volume":"27","author":"van Praag Veroniek","year":"2018","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0380","doi-asserted-by":"crossref","first-page":"e0246958","DOI":"10.1371\/journal.pone.0246958","article-title":"Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network","volume":"16","author":"de Pinieux","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0385","series-title":"Soft tissue and bone tumours","year":"2020"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0390","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jor.24463","article-title":"Survival and prognosis of chondrosarcoma subtypes: SEER database analysis","volume":"38","author":"Amer","year":"2020","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0395","doi-asserted-by":"crossref","first-page":"926008","DOI":"10.3389\/fsurg.2022.926008","article-title":"The clinicopathological characteristics and prognosis of young patients with chondrosarcoma of bone","volume":"9","author":"Xie","year":"2022","journal-title":"Front Surg"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.013_bib0400","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ng.1004","article-title":"Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome","volume":"43","author":"Pansuriya","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0405","first-page":"110","article-title":"Hereditary multiple exostoses: a review of clinical appearance and metabolic pattern","volume":"13","author":"Beltrami","year":"2016","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.013_bib0410","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1634\/theoncologist.2011-0200","article-title":"Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients","volume":"16","author":"Verdegaal","year":"2011","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.bulcan.2024.07.013_bib0415","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/ajmg.a.61530","article-title":"Natural history of Ollier disease and Maffucci syndrome: Patient survey and review of clinical literature","volume":"182","author":"El Abiad","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0420","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00256-023-04389-2","article-title":"Is total-body MRI useful as a screening tool to rule out malignant progression in patients with multiple osteochondromas? Results in a single-center cohort of 319 adult patients","volume":"53","author":"Van der Woude","year":"2024","journal-title":"Skeletal Radiol"},{"issue":"7","key":"10.1016\/j.bulcan.2024.07.013_bib0425","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00256-015-2123-7","article-title":"Is there a role for diffusion-weighted MRI (DWI) in the diagnosis of central cartilage tumors?","volume":"44","author":"Douis","year":"2015","journal-title":"Skeletal Radiol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.013_bib0430","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/radiol.10082120","article-title":"Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging","volume":"255","author":"Bernard","year":"2010","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.bulcan.2024.07.013_bib0435","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1007\/s00330-013-2913-z","article-title":"Dynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma","volume":"23","author":"De Coninck","year":"2013","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0440","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00330-017-4947-0","article-title":"What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?","volume":"28","author":"Douis","year":"2018","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0445","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00330-013-3003-y","article-title":"MRI differentiation of low-grade from high-grade appendicular chondrosarcoma","volume":"24","author":"Douis","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0450","doi-asserted-by":"crossref","first-page":"109579","DOI":"10.1016\/j.ejrad.2021.109579","article-title":"The role of imaging in differentiating low-grade and high-grade central chondral tumours","volume":"137","author":"Sharif","year":"2021","journal-title":"Eur J Radiol"},{"issue":"5","key":"10.1016\/j.bulcan.2024.07.013_bib0455","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00256-012-1521-3","article-title":"The imaging of cartilaginous bone tumours. II. Chondrosarcoma","volume":"42","author":"Douis","year":"2013","journal-title":"Skeletal Radiol"},{"issue":"7","key":"10.1016\/j.bulcan.2024.07.013_bib0460","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.pathol.2017.08.003","article-title":"A diagnostic approach to bone tumours","volume":"49","author":"Flanagan","year":"2017","journal-title":"Pathology"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.013_bib0465","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00256-003-0706-1","article-title":"Dedifferentiated chondrosarcoma of the appendicular skeleton: MRI-pathological correlation","volume":"32","author":"MacSweeney","year":"2003","journal-title":"Skeletal Radiol"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.013_bib0470","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00256-003-0668-3","article-title":"Clear cell chondrosarcoma: radiographic, computed tomographic, and magnetic resonance findings in 34 patients with pathologic correlation","volume":"32","author":"Collins","year":"2003","journal-title":"Skeletal Radiol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0475","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00256-020-03558-x","article-title":"Mesenchymal chondrosarcoma: imaging features and clinical findings","volume":"50","author":"Ghafoor","year":"2021","journal-title":"Skeletal Radiol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0480","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00256-020-03578-7","article-title":"The importance of MRI review following the diagnosis of atypical cartilaginous tumour using image-guided needle biopsy","volume":"50","author":"Saifuddin","year":"2021","journal-title":"Skeletal Radiol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.013_bib0485","first-page":"CD010778","article-title":"Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones","volume":"3","author":"Dierselhuis","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.013_bib0490","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jso.27123","article-title":"Can low-grade chondrosarcoma in flat bones be treated with intralesional curettage and cryotherapy?","volume":"127","author":"Park","year":"2023","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.013_bib0495","doi-asserted-by":"crossref","first-page":"103410","DOI":"10.1016\/j.otsr.2022.103410","article-title":"Long-term follow up of patients with low-grade chondrosarcoma in the appendicular skeleton treated by extended curettage and liquid nitrogen","volume":"109","author":"El Masry","year":"2023","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0500","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2021.04.017","article-title":"Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: results from the EUROpean Bone over 40 sarcoma study","volume":"151","author":"Hompland","year":"2021","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.013_bib0505","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.21873\/anticanres.14097","article-title":"Chondrosarcoma of the chest wall: a review of 53 cases from two institutions","volume":"40","author":"Lenze","year":"2020","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0510","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/SAP.0000000000003334","article-title":"Chondrosarcoma of the chest wall: a single institution review of 50 cases","volume":"90","author":"Laitinen","year":"2023","journal-title":"Ann Plast Surg"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.013_bib0515","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.spinee.2021.04.021","article-title":"Chondrosarcoma of the spine: a narrative review","volume":"21","author":"Pennington","year":"2021","journal-title":"Spine J"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0520","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1142\/S2424835519500085","article-title":"Chondrosarcoma of the hand bones: a report of 6 cases and review of the literature","volume":"24","author":"Garcia-Jimenez","year":"2019","journal-title":"J Hand Surg Asian Pac Vol"},{"issue":"14","key":"10.1016\/j.bulcan.2024.07.013_bib0525","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.ejca.2007.06.016","article-title":"Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group","volume":"43","author":"Grimer","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0530","doi-asserted-by":"crossref","first-page":"100456","DOI":"10.1016\/j.jbo.2022.100456","article-title":"Appendicular dedifferentiated chondrosarcoma: a management and survival study from the SEER database","volume":"37","author":"Gonzalez","year":"2022","journal-title":"J Bone Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.013_bib0535","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ijrobp.2020.03.041","article-title":"Postoperative radiation therapy in patients with extracranial chondrosarcoma: a joint study of the French Sarcoma Group and Rare Cancer Network","volume":"107","author":"Terlizzi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.013_bib0540","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/1097-0347(200007)22:4<408::AID-HED15>3.0.CO;2-H","article-title":"National cancer database report on chondrosarcoma of the head and neck","volume":"22","author":"Koch","year":"2000","journal-title":"Head Neck"},{"issue":"9\u201310","key":"10.1016\/j.bulcan.2024.07.013_bib0545","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1159\/000509386","article-title":"Skull base chordomas and chondrosarcomas","volume":"110","author":"Kremenevski","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.013_bib0550","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.jocn.2009.05.003","article-title":"A systematic review of intracranial chondrosarcoma and survival","volume":"16","author":"Bloch","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0555","doi-asserted-by":"crossref","unstructured":"Palmisciano P., Haider A.S., Sabahi M., Nwagwu C.D., Bin Alamer O., Scalia G., et al. Primary skull base chondrosarcomas: a systematic review. Cancers (Basel) 2021;13(23):5960.","DOI":"10.3390\/cancers13235960"},{"issue":"12","key":"10.1016\/j.bulcan.2024.07.013_bib0560","doi-asserted-by":"crossref","first-page":"e0208786","DOI":"10.1371\/journal.pone.0208786","article-title":"Surgery and protontherapy in Grade I and II skull base chondrosarcoma: a comparative retrospective study","volume":"13","author":"Simon","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0565","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11060-021-03764-0","article-title":"Long-term outcomes of grade I\/II skull base chondrosarcoma: an insight into the role of surgery and upfront radiotherapy","volume":"153","author":"Hasegawa","year":"2021","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.013_bib0570","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ijrobp.2008.12.055","article-title":"Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report","volume":"75","author":"Ares","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0575","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/neuonc\/nov154","article-title":"Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute","volume":"18","author":"Weber","year":"2016","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0580","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13014-020-01711-3","article-title":"Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy","volume":"15","author":"Basler","year":"2020","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.013_bib0585","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0040-1722228","article-title":"Impact of type of treatment center and access to care on mortality and survival for skull base chordoma and chondrosarcoma","volume":"83","author":"Holtzman","year":"2022","journal-title":"J Neurol Surg B Skull Base"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0590","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2020.11.014","article-title":"ESTRO ACROP guideline for target volume delineation of skull base tumors","volume":"156","author":"Combs","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0595","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.wneu.2021.03.097","article-title":"Outcomes and patterns of care in adult skull base chondrosarcoma patients in the United States","volume":"150","author":"Patel","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0600","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.radonc.2021.02.012","article-title":"Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma","volume":"158","author":"De Leo","year":"2021","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0605","doi-asserted-by":"crossref","first-page":"300","DOI":"10.14338\/IJPT-16-00019.1","article-title":"Mesenchymal chondrosarcoma","volume":"3","author":"Mendenhall","year":"2016","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0610","first-page":"100510","article-title":"Presenting features and overall survival of chondrosarcoma of the pelvis","volume":"30","author":"Brown","year":"2022","journal-title":"Cancer Treat Res Commun"},{"issue":"20","key":"10.1016\/j.bulcan.2024.07.013_bib0615","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/cncr.28845","article-title":"Outcome of advanced, unresectable conventional central chondrosarcoma","volume":"120","author":"van Maldegem","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0620","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10147-015-0870-z","article-title":"Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma","volume":"21","author":"Outani","year":"2016","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.013_bib0625","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000504854","article-title":"Lung metastasectomy improves survival in patients affected by grade 2 and 3 chondrosarcoma","volume":"43","author":"Sambri","year":"2020","journal-title":"Oncol Res Treat"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.013_bib0630","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijrobp.2022.05.017","article-title":"Local control outcomes using stereotactic body radiation therapy or surgical resection for metastatic sarcoma","volume":"114","author":"Gutkin","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.bulcan.2024.07.013_bib0635","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/annonc\/mdt374","article-title":"Advanced chondrosarcomas: role of chemotherapy and survival","volume":"24","author":"Italiano","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0640","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1634\/theoncologist.2017-0574","article-title":"Outcome of first-line systemic treatment for unresectable conventional, dedifferentiated, mesenchymal, and clear cell chondrosarcoma","volume":"24","author":"van Maldegem","year":"2019","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.013_bib0645","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11864-022-00951-7","article-title":"Systemic therapy for chondrosarcoma","volume":"23","author":"Rock","year":"2022","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2024.07.013_bib0650","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00280-012-1968-x","article-title":"Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas","volume":"70","author":"Bernstein-Molho","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0655","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cncr.30379","article-title":"Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor","volume":"123","author":"Schuetze","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0660","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/cncr.32515","article-title":"Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma","volume":"126","author":"Chow","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0665","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.03.039","article-title":"Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study","volume":"150","author":"Duffaud","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0670","doi-asserted-by":"crossref","first-page":"811687","DOI":"10.3389\/fonc.2022.811687","article-title":"Anlotinib for recurrent or metastatic primary malignant bone tumor: a multicenter, single-arm trial","volume":"12","author":"Tang","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0675","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2353\/ajpath.2006.050001","article-title":"Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation","volume":"168","author":"Tiet","year":"2006","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.bulcan.2024.07.013_bib0680","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/annonc\/mdt391","article-title":"GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group\/US and French National Cancer Institute Single-Arm Phase II Collaborative Study","volume":"24","author":"Italiano","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.013_bib0685","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1078-0432.CCR-06-1696","article-title":"The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells","volume":"13","author":"Sakimura","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.bulcan.2024.07.013_bib0690","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/modpathol.2016.108","article-title":"Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype","volume":"29","author":"Kostine","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0695","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13569-016-0064-0","article-title":"Response to anti-PD1 therapy with nivolumab in metastatic sarcomas","volume":"6","author":"Paoluzzi","year":"2016","journal-title":"Clin Sarcoma Res"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.013_bib0700","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1158\/1078-0432.CCR-09-1267","article-title":"A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignancies","volume":"16","author":"Camidge","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"16","key":"10.1016\/j.bulcan.2024.07.013_bib0705","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1158\/1078-0432.CCR-23-0974","article-title":"Preclinical characterization and phase I trial results of INBRX-109, a third-generation, recombinant, humanized, death receptor 5 agonist antibody, in chondrosarcoma","volume":"29","author":"Subbiah","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.013_bib0710","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejca.2014.11.007","article-title":"Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study","volume":"51","author":"Frezza","year":"2015","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.bulcan.2024.07.013_bib0715","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/cncr.23457","article-title":"Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups","volume":"112","author":"Dantonello","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.013_bib0720","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1470-2045(15)70098-7","article-title":"Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study","volume":"16","author":"Kawai","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0725","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13569-020-00138-4","article-title":"Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma","volume":"10","author":"Tansir","year":"2020","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0730","doi-asserted-by":"crossref","first-page":"1086677","DOI":"10.3389\/fonc.2022.1086677","article-title":"Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: a case report","volume":"12","author":"Blum","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0735","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s12885-016-2511-y","article-title":"Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma","volume":"16","author":"Morioka","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bulcan.2024.07.013_bib0740","doi-asserted-by":"crossref","first-page":"608279","DOI":"10.1155\/2015\/608279","article-title":"Mesenchymal chondrosarcoma in children and young adults: a single institution retrospective review","volume":"2015","author":"Bishop","year":"2015","journal-title":"Sarcoma"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:21:01Z","timestamp":1762104061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455125000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0007455125000785"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.07.013","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chondrosarcomas: Multidisciplinary review and practical recommendations, on behalf of GroupOs","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}